Literature DB >> 26812119

Pro-atherogenic role of smooth muscle Nox4-based NADPH oxidase.

Xiaoyong Tong1, Alok R Khandelwal2, Xiaojuan Wu3, Zaicheng Xu4, Weimin Yu3, Caiyu Chen4, Wanzhou Zhao5, Jian Yang4, Zhexue Qin6, Robert M Weisbrod2, Francesca Seta2, Tetsuro Ago7, Kin Sing Stephen Lee8, Bruce D Hammock8, Junichi Sadoshima9, Richard A Cohen2, Chunyu Zeng4.   

Abstract

UNLABELLED: Nox4-based NADPH oxidase is a major reactive oxygen species-generating enzyme in the vasculature, but its role in atherosclerosis remains controversial.
OBJECTIVE: Our goal was to investigate the role of smooth muscle Nox4 in atherosclerosis. APPROACH AND
RESULTS: Atherosclerosis-prone conditions (disturbed blood flow and Western diet) increased Nox4 mRNA level in smooth muscle of arteries. To address whether upregulated smooth muscle Nox4 under atherosclerosis-prone conditions was directly involved in the development of atherosclerosis, mice carrying a human Nox4 P437H dominant negative mutation (Nox4DN), specifically in smooth muscle, were generated on a FVB/N ApoE deficient genetic background to counter the effect of increased smooth muscle Nox4. Nox4DN significantly decreased aortic stiffness and atherosclerotic lesions, with no effect on blood pressure. Gene analysis indicated that soluble epoxide hydrolase 2 (sEH) was significantly downregulated in Nox4DN smooth muscle cells (SMC), at both mRNA and protein levels. Downregulation of sEH by siRNA decreased SMC proliferation and migration, and suppressed inflammation and macrophage adhesion to SMC.
CONCLUSIONS: Downregulation of smooth muscle Nox4 inhibits atherosclerosis by suppressing sEH, which, at least in part, accounts for inhibition of SMC proliferation, migration and inflammation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Nox4; Smooth muscle; Soluble epoxide hydrolase 2

Mesh:

Substances:

Year:  2016        PMID: 26812119      PMCID: PMC5008453          DOI: 10.1016/j.yjmcc.2016.01.020

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  44 in total

1.  Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.

Authors:  Z Yu; F Xu; L M Huse; C Morisseau; A J Draper; J W Newman; C Parker; L Graham; M M Engler; B D Hammock; D C Zeldin; D L Kroetz
Journal:  Circ Res       Date:  2000-11-24       Impact factor: 17.367

2.  A model of disturbed flow-induced atherosclerosis in mouse carotid artery by partial ligation and a simple method of RNA isolation from carotid endothelium.

Authors:  Douglas Nam; Chih-Wen Ni; Amir Rezvan; Jin Suo; Klaudia Budzyn; Alexander Llanos; David G Harrison; Don P Giddens; Hanjoong Jo
Journal:  J Vis Exp       Date:  2010-06-22       Impact factor: 1.355

3.  Evolution and involution of atherosclerosis and its relationship with vascular reactivity in hypercholesterolemic rabbits.

Authors:  Michiko Regina Ozaki; Eros Antonio de Almeida
Journal:  Exp Toxicol Pathol       Date:  2011-10-22

4.  The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus.

Authors:  Adriana Zuccollo; Chaomei Shi; Roberto Mastroianni; Karlene A Maitland-Toolan; Robert M Weisbrod; Mengwei Zang; Shanqin Xu; Bingbing Jiang; Jennifer M Oliver-Krasinski; Antonio J Cayatte; Stefano Corda; Gilbert Lavielle; Tony J Verbeuren; Richard A Cohen
Journal:  Circulation       Date:  2005-10-31       Impact factor: 29.690

5.  NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart.

Authors:  Junya Kuroda; Tetsuro Ago; Shouji Matsushima; Peiyong Zhai; Michael D Schneider; Junichi Sadoshima
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

6.  Activation of thromboxane receptor upregulates interleukin (IL)-1beta-induced VCAM-1 expression through JNK signaling.

Authors:  Hossein Bayat; Shanqin Xu; David Pimentel; Richard A Cohen; Bingbing Jiang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-11-21       Impact factor: 8.311

Review 7.  NADPH oxidases: functions and pathologies in the vasculature.

Authors:  Bernard Lassègue; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311

Review 8.  Noninvasive assessment of preclinical atherosclerosis.

Authors:  Helen A Lane; Jamie C Smith; J Stephen Davies
Journal:  Vasc Health Risk Manag       Date:  2006

9.  The NADPH oxidase Nox4 has anti-atherosclerotic functions.

Authors:  Christoph Schürmann; Flavia Rezende; Christoph Kruse; Yakub Yasar; Oliver Löwe; Christian Fork; Bart van de Sluis; Rolf Bremer; Norbert Weissmann; Ajay M Shah; Hanjoong Jo; Ralf P Brandes; Katrin Schröder
Journal:  Eur Heart J       Date:  2015-09-17       Impact factor: 29.983

10.  Regulation of ROS signal transduction by NADPH oxidase 4 localization.

Authors:  Kai Chen; Michael T Kirber; Hui Xiao; Yu Yang; John F Keaney
Journal:  J Cell Biol       Date:  2008-06-23       Impact factor: 10.539

View more
  22 in total

Review 1.  Reactive Oxygen Species in Metabolic and Inflammatory Signaling.

Authors:  Steven J Forrester; Daniel S Kikuchi; Marina S Hernandes; Qian Xu; Kathy K Griendling
Journal:  Circ Res       Date:  2018-03-16       Impact factor: 17.367

2.  NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis.

Authors:  Andrey Lozhkin; Aleksandr E Vendrov; Hua Pan; Samuel A Wickline; Nageswara R Madamanchi; Marschall S Runge
Journal:  J Mol Cell Cardiol       Date:  2016-12-14       Impact factor: 5.000

3.  Smooth Muscle Nitric Oxide Responsiveness and Clinical Maturation of Hemodialysis Arteriovenous Fistulae.

Authors:  Xiaoyong Tong; Xiuyun Hou; Christopher Wason; Tal Kopel; Richard A Cohen; Laura M Dember
Journal:  Am J Pathol       Date:  2017-08-17       Impact factor: 4.307

Review 4.  Redox control of vascular smooth muscle cell function and plasticity.

Authors:  Brittany G Durgin; Adam C Straub
Journal:  Lab Invest       Date:  2018-02-20       Impact factor: 5.662

Review 5.  The Role of NADPH Oxidases in the Etiology of Obesity and Metabolic Syndrome: Contribution of Individual Isoforms and Cell Biology.

Authors:  Evan DeVallance; Yao Li; Michael J Jurczak; Eugenia Cifuentes-Pagano; Patrick J Pagano
Journal:  Antioxid Redox Signal       Date:  2019-10-01       Impact factor: 8.401

Review 6.  Disturbed flow's impact on cellular changes indicative of vascular aneurysm initiation, expansion, and rupture: A pathological and methodological review.

Authors:  Kevin Sunderland; Jingfeng Jiang; Feng Zhao
Journal:  J Cell Physiol       Date:  2021-09-06       Impact factor: 6.384

7.  NADPH Oxidase 4 Regulates Inflammation in Ischemic Heart Failure: Role of Soluble Epoxide Hydrolase.

Authors:  Mark D Stevenson; Chandrika Canugovi; Aleksandr E Vendrov; Takayuki Hayami; Dawn E Bowles; Karl-Heinz Krause; Nageswara R Madamanchi; Marschall S Runge
Journal:  Antioxid Redox Signal       Date:  2018-12-28       Impact factor: 8.401

8.  NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosis.

Authors:  Elyse Di Marco; Stephen P Gray; Kit Kennedy; Cedric Szyndralewiez; Alicia N Lyle; Bernard Lassègue; Kathy K Griendling; Mark E Cooper; Harald H H W Schmidt; Karin A M Jandeleit-Dahm
Journal:  Free Radic Biol Med       Date:  2016-07-19       Impact factor: 7.376

9.  Endothelial Nox4-based NADPH oxidase regulates atherosclerosis via soluble epoxide hydrolase.

Authors:  Pingping Hu; Xiaojuan Wu; Alok R Khandelwal; Weimin Yu; Zaicheng Xu; Lili Chen; Jian Yang; Robert M Weisbrod; Kin Sing Stephen Lee; Francesca Seta; Bruce D Hammock; Richard A Cohen; Chunyu Zeng; Xiaoyong Tong
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-02-07       Impact factor: 5.187

10.  The hydrogen-peroxide producing NADPH oxidase 4 does not limit neointima development after vascular injury in mice.

Authors:  Giulia K Buchmann; Christoph Schürmann; Manuela Spaeth; Wesley Abplanalp; Lukas Tombor; David John; Timothy Warwick; Flávia Rezende; Andreas Weigert; Ajay M Shah; Martin-Leo Hansmann; Norbert Weissmann; Stefanie Dimmeler; Katrin Schröder; Ralf P Brandes
Journal:  Redox Biol       Date:  2021-06-18       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.